Study of PCLX-001 in R/R Advanced Solid Malignancies and B-cell Lymphoma

Clinical trial NCT04836195 · COMPLETED

Trial details

NCT number: NCT04836195
Sponsor: Pacylex Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

B-cell Non Hodgkin Lymphoma Advanced Solid Tumor

Start date: 2021-09-14
Primary completion: 2024-10-28
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.